These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 36234758)

  • 21. Exploring the mechanisms underlying the therapeutic effect of the
    Qing L; Pan B; He Y; Liu Y; Zhao M; Niu B; Gao X
    Aging (Albany NY); 2022 Nov; 14(22):9103-9127. PubMed ID: 36403263
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanisms and network pharmacological analysis of Yangyin Fuzheng Jiedu prescription in the treatment of hepatocellular carcinoma.
    Xie Y; Yan F; Wang X; Yu L; Yan H; Pu Q; Li W; Yang Z
    Cancer Med; 2023 Feb; 12(3):3237-3259. PubMed ID: 36043445
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exploring the Molecular Mechanisms of Huaier on Modulating Metabolic Reprogramming of Hepatocellular Carcinoma: A Study based on Network Pharmacology, Molecular Docking and Bioinformatics.
    Wan Y; Jiang H; Liu Z; Bai C; Lian Y; Zhang C; Zhang Q; Huang J
    Curr Pharm Des; 2024; 30(24):1894-1911. PubMed ID: 38747231
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The mechanism and experimental verification of Ixeris sonchifolia promoting apoptosis of hepatocellular carcinoma based on network pharmacology: Ixeris sonchifolia Induces Hepatocellular Carcinoma Apoptosis via the PI3K/AKT Pathway.
    Liu BJ; Guan YY; Qiao LX; Zhang JM; Li AJ; Yang PX; Gao YX; Chen DX; Wang CX; Wu J
    J Ethnopharmacol; 2024 Jun; 327():117994. PubMed ID: 38437889
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chinese herbal medicine-derived compounds for cancer therapy: a focus on hepatocellular carcinoma.
    Hu Y; Wang S; Wu X; Zhang J; Chen R; Chen M; Wang Y
    J Ethnopharmacol; 2013 Oct; 149(3):601-12. PubMed ID: 23916858
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Investigating the molecular mechanism of Qizhu anticancer prescription in inhibiting hepatocellular carcinoma based on high-resolution mass spectrometry and network pharmacology.
    Sun J; Ma M; Zhong X; Li J; Yi J; Zhang R; Liu X; Peng L; Sun X; Feng W; Hu R; Huang Q; Lv M; Fan K; Zhou X
    J Ethnopharmacol; 2024 Jun; 328():117985. PubMed ID: 38417600
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of the anti-inflammatory mechanism of quercetin 3,7-dirhamnoside using an integrated pharmacology strategy.
    He X; Sun Y; Lu X; Yang F; Li T; Deng C; Song J; Huang X
    Chem Biol Drug Des; 2023 Dec; 102(6):1534-1552. PubMed ID: 37806949
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Frankincense myrrh attenuates hepatocellular carcinoma by regulating tumor blood vessel development through multiple epidermal growth factor receptor-mediated signaling pathways.
    Zheng P; Huang Z; Tong DC; Zhou Q; Tian S; Chen BW; Ning DM; Guo YM; Zhu WH; Long Y; Xiao W; Deng Z; Lei YC; Tian XF
    World J Gastrointest Oncol; 2022 Feb; 14(2):450-477. PubMed ID: 35317323
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A network pharmacology integrated serum pharmacochemistry strategy for uncovering efficacy of YXC on hepatocellular carcinoma.
    Zhou TT; Zhu WJ; Feng H; Ni Y; Li ZW; Sun DD; Li L; Tan JN; Yu CT; Shen WX; Cheng HB
    J Ethnopharmacol; 2024 Jan; 319(Pt 1):117125. PubMed ID: 37699493
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exploring the mechanism of Jianpi Huatan recipe in protecting hepatocellular carcinoma based on network pharmacology.
    Zhang C; Xiang H; Wang J; Shao G; Ding P; Gao Y; Xu H; Ji G; Wu T
    J Ethnopharmacol; 2023 Dec; 317():116676. PubMed ID: 37279814
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fuzheng Jiedu Xiaoji formulation inhibits hepatocellular carcinoma progression in patients by targeting the AKT/CyclinD1/p21/p27 pathway.
    Yang X; Feng Y; Liu Y; Ye X; Ji X; Sun L; Gao F; Zhang Q; Li Y; Zhu B; Wang X
    Phytomedicine; 2021 Jul; 87():153575. PubMed ID: 33984593
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The anti-hepatocellular carcinoma effect of Aidi injection was related to the synergistic action of cantharidin, formononetin, and isofraxidin through BIRC5, FEN1, and EGFR.
    Lu S; Huang J; Zhang J; Wu C; Huang Z; Tao X; You L; Stalin A; Chen M; Li J; Tan Y; Wu Z; Geng L; Li Z; Fan Q; Liu P; Lin Y; Zhao C; Wu J
    J Ethnopharmacol; 2024 Jan; 319(Pt 2):117209. PubMed ID: 37757991
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanism underlying the effect of Pulsatilla decoction in hepatocellular carcinoma treatment: a network pharmacology and in vitro analysis.
    Liu K; Cao Z; Huang S; Kong F
    BMC Complement Med Ther; 2023 Nov; 23(1):405. PubMed ID: 37950195
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Integrating Network Pharmacology and Bioinformatics to Explore the Effects of Dangshen (
    Yu Y; Ding S; Xu X; Yan D; Fan Y; Ruan B; Zhang X; Zheng L; Jie W; Zheng S
    Drug Des Devel Ther; 2023; 17():659-673. PubMed ID: 36883114
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Erianin, the main active ingredient of Dendrobium chrysotoxum Lindl, inhibits precancerous lesions of gastric cancer (PLGC) through suppression of the HRAS-PI3K-AKT signaling pathway as revealed by network pharmacology and in vitro experimental verification.
    Wang Y; Chu F; Lin J; Li Y; Johnson N; Zhang J; Gai C; Su Z; Cheng H; Wang L; Ding X
    J Ethnopharmacol; 2021 Oct; 279():114399. PubMed ID: 34246740
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anhydroicaritin suppresses tumor progression via the PI3K/AKT signaling pathway in hepatocellular carcinoma.
    Wang H; Chen W; Cui Y; Gong H; Tang A
    Aging (Albany NY); 2023 Aug; 15(15):7831-7843. PubMed ID: 37556351
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A systematic approach to decode the mechanism of Cornus in the treatment of hepatocellular carcinoma (HCC).
    Shen HY; Li XQ; Fan WQ; Wang YW; Huang F; Wu JQ; Zhang W; Feng XS; Chao X
    Eur J Pharmacol; 2021 Oct; 909():174405. PubMed ID: 34384755
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Xiao-Luo-Wan treats propylthiouracil-induced goiter with hypothyroidism in rats through the PI3K-AKT/RAS pathways based on UPLC/MS and network pharmacology.
    Dong S; Liu Q; Jiang M; Ma Q; Huang Q; Liu T; Li Y; Ni L; Shi Y
    J Ethnopharmacol; 2022 May; 289():115045. PubMed ID: 35101570
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Network Pharmacology Prediction and Molecular Docking-Based Strategy to Discover the Potential Pharmacological Mechanism of Huai Hua San Against Ulcerative Colitis.
    Liu J; Liu J; Tong X; Peng W; Wei S; Sun T; Wang Y; Zhang B; Li W
    Drug Des Devel Ther; 2021; 15():3255-3276. PubMed ID: 34349502
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Systems Network Pharmacology-Based Prediction and Analysis of Potential Targets and Pharmacological Mechanism of
    Hu Y; Yang L; Lu Y; Wang Y; Jiang J; Liu Y; Cao Q
    Evid Based Complement Alternat Med; 2022; 2022():2116006. PubMed ID: 36193154
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.